In the A-share market, investors often hear the words "drink and eat medicine", which is not literally the meaning of the word, but refers to the purchase of white wine, medical sector stocks, this situation generally occurs in the process of a sustained decline in the market, investors through the purchase of such stocks for hedging, of course, for some prudent investors
Medicine ETFs are a great way to get the most out of your life, but they are also a great way to get the most out of your life, and they are a great way to get the most out of your life.
Pharmaceutical ETF funds are mainly:
Guangdong CSI All-Index Pharmaceutical ETF (159938), closely tracking the All-Index Pharmaceutical Index with a tracking error of 0.03%, was established on December 1, 2014, with a medium-to-high risk rating, and belongs to the over-the-counter (OTC) fund, i.e., investors can long positions in stocks such as Hengrui Pharmaceuticals, Watson Biologicals, Tablet Yellow and WuXi AppTec.
The Efonda CSI 300 Pharmaceuticals & Health ETF (512010), which closely tracks the CSI 300 Pharmaceuticals & Health Index with a tracking error of 0.08 percent and an inception date of Sept. 23, 2013, is an over-the-counter fund, which is heavily weighted in stocks such as Hengrui Pharmaceuticals, WuXi Biologicals, Aier Ophthalmology and Yunnan Baiyao.
Huaxia Pharmaceuticals ETF (510660), which closely tracks the SSE Pharmaceuticals & Healthcare Sector Index with a tracking error of 0.19%, was established on March 28, 2013 and is an over-the-counter fund, with long positions in Hengrui Medicine, Tablets, Fosun Pharmaceuticals and Shanghai Pharmaceuticals.
Caritas CSI Healthcare ETF (512610), which closely tracks the CSI Healthcare Index with a tracking error of 0.04%, was founded on June 13, 2014, and is an over-the-counter fund, which has long positions in stocks such as Hengrui Medicine, PharmaTech, Aier Ophthalmology and Yunnan Baiyao.
Investment involves risks, so be careful when entering the market